Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

19 Mar 2019

CRO Sector M&A drivers and market trends

Contract Research Organisations (CROs) typically provide discovery and development services to the pharmaceutical, biotechnology and medical devices industries (frequently referred…

26 Mar 2019

Factors driving consolidation in the CDMO space – Pharma’s Almanac

Despite the completion of several megadeals, the pharmaceutical contract manufacturing sector remains fragmented. More consolidation can be expected as outsourcing…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:

23 Jun 2019 - 09.00am-6.00pm

DIA 2019 Global Annual Meeting

DIA’s Global Annual Meeting (DIA 2019) gathers stakeholders from across the world to openly knowledge share, generating insights beyond boundaries…

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office